Assort Health Secures $120 M Series C, Valued at $1.2 B, to Accelerate AI‑Powered Patient Journey Platform
San Francisco‑based Assort Health announced a fresh $120 million Series C financing led by Menlo Ventures, pushing the company’s post‑money valuation to $1.2 billion. The round brings the startup’s total capital raised to more than $222 million, underscoring investor confidence in its end‑to‑end AI platform for healthcare access. A market burden ripe for automation Administrative overhead still consumes roughly twice…
